Urology Times 50 Innovations Series: Urinary molecular biomarkers in prostate cancer

“Our ability to develop innovative technologies and approaches continues to evolve. We have newer molecular profiling techniques that are being applied to urine at the moment,” says Simpa Salami, MD, MPH.

Urology Times® is celebrating its 50th anniversary in 2022. To mark the occasion, we are highlighting 50 of the top innovations and developments that have transformed the field of urology over the past 50 years. In this installment, Simpa Salami, MD, MPH, discusses the development of urinary biomarkers in prostate cancer detection. Salami is an assistant professor of urology at the University of Michigan, Ann Arbor.

Related Videos
Veda Giri, MD, answers a question during a Zoom video interview
Genetic testing for prostate cancer | Image credit: © ktsdesign - stock.adobe.com
DNA molecules
DNA strand illustration
illustration of double helix
illustration of DNA molecule
© 2023 MJH Life Sciences

All rights reserved.